from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2151c/ftsQ

LFCtreatmentdescriptionclass of inhibitor

0.268

Amikacinug/mL Amikacintranslation

-1.029

Cap5-10ug/mL Capreomycintranslation

-0.660

Rox10-50 ug/mL Roxithromycintranslation

0.122

SM2-5 ug/mL Streptomycintranslation

-2.237

Tet5-10 ug/mL Tetracyclinetranslation

-0.795

Rif0.2-5ug/mL Rifampicintranscription

-0.354

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.876

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.473

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.142

CPZ10-50 ug/mL Chlorpromazinerespiration

0.272

Clofazimine10-13 ug/mL Clofaziminerespiration

0.281

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.966

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.737

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.301

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.252

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.464

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.818

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.811

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.560

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.711

KCN5-20 ug/mL Potassium cyaniderespiration

0.258

NaN30.2-2 mM Sodium aziderespiration

0.081

Nigericin50 uM Nigericinrespiration

0.052

TRC10-150 ug/mL Triclosanrespiration

-0.508

TRZ10-25 ug/mL Thioridazinerespiration

-0.903

Valinomycin0.5-10 uM Valinomycinrespiration

1.565

ZnSO42 mM ZnSO4respiration

0.969

menadione6-10 ug/mL Menadionerespiration

-0.251

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.196

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.303

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.090

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.432

NRP_1Non-replicating persistence stage 1dosRassociated

0.444

Amp0.2mg/mL AmpicillincellWall

0.714

Cephalexin20-100 ug/mL CephalexincellWall

-0.453

Cerulenin0.32-5 ug/mL CerulenincellWall

0.144

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.082

EMB10-20 ug/mL EthambutolcellWall

0.489

Eta12-40 ug/mL EthionamidecellWall

0.669

INH0.2-0.4 ug/mL IsoniazidcellWall

0.263

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.203

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.704

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.099

BZA0.12 mg/mL BenzamidearomaticAmides

-0.091

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.518

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.069

H2O24 mM hydrogen peroxideDNAdamaging

-0.294

Levo10 ug/mL LevofloxacinDNAdamaging

-0.985

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.410

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.608

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.420

UVUV-irradiationDNAdamaging

-0.399

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.188

Antimycin12.5-50 ug/mL Antimycin A?

0.710

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.489

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.201

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.393

PA8240.2-2 ug/mL PA-824?

0.571

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.451

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.559

Verapamil50 uM Verapamil?

0.114

mercaptoethanol2 mM 2-Mercaptoethanol?

0.547

methoxatin10-20 ug/mL Methoxatin?